Generation Bio Co Stock Price on October 1, 2024
| GBIO Stock | USD 1.37 0.05 3.79% |
Below is the normalized historical share price chart for Generation Bio Co extending back to June 12, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Generation Bio stands at 1.37, as last reported on the 23rd of November, with the highest price reaching 1.48 and the lowest price hitting 1.29 during the day.
If you're considering investing in Generation Stock, it is important to understand the factors that can impact its price. Generation Bio holds Efficiency (Sharpe) Ratio of -0.18, which attests that the entity had a -0.18% return per unit of risk over the last 3 months. Generation Bio exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Generation Bio's Market Risk Adjusted Performance of (0.25), risk adjusted performance of (0.12), and Standard Deviation of 5.19 to validate the risk estimate we provide.
As of the 23rd of November 2024, Total Stockholder Equity is likely to drop to about 182.5 M. In addition to that, Common Stock Total Equity is likely to drop to 4,180. At this time, Generation Bio's Price Book Value Ratio is very stable compared to the past year. As of the 23rd of November 2024, Price To Book Ratio is likely to grow to 0.55, while Price To Sales Ratio is likely to drop 19.69. Generation Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of June 2020 | 200 Day MA 2.7566 | 50 Day MA 2.2886 | Beta 2.818 |
Generation |
Sharpe Ratio = -0.1849
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GBIO |
Estimated Market Risk
| 5.2 actual daily | 46 54% of assets are more volatile |
Expected Return
| -0.96 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.18 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Generation Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Generation Bio by adding Generation Bio to a well-diversified portfolio.
Price Book 0.8442 | Enterprise Value Ebitda (0.34) | Price Sales 4.7447 | Shares Float 48.8 M | Wall Street Target Price 7.5 |
Related Headline
Kronos Bio Headline on 1st of October 2024
Plexium Announces Appointment of Jorge F. DiMartino, M.D., P... by finance.yahoo.com
Plexium, Inc. , a leading next-generation targeted protein degradation company, today announced that it has appointed Jorge F. DiMartino, M.D., Ph.D., as Chief Medical Officer and Executive Vice President of Clinical and Translational Development. Dr. DiMartino will be responsible for leading Plexiums clinical function and overseeing the advancement of development stage programs against high-value targets such as SMARCA2, IKZF2, CDK2, CRAF and others.
Generation Bio Valuation on October 1, 2024
It is possible to determine the worth of Generation Bio on a given historical date. On October 1, 2024 Generation was worth 2.47 at the beginning of the trading date compared to the closed value of 2.36. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Generation Bio stock. Still, in general, we apply an absolute valuation method to find Generation Bio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Generation Bio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Generation Bio's related companies.
| Open | High | Low | Close | Volume | |
| 2.39 | 2.54 | 2.32 | 2.47 | 123,174 | |
10/01/2024 | 2.47 | 2.49 | 2.30 | 2.36 | 101,177 |
| 2.32 | 2.74 | 2.31 | 2.51 | 303,283 |
| Backtest Generation Bio | | | Generation Bio History | | | Generation Bio Valuation | Previous | Next |
Generation Bio Trading Date Momentum on October 1, 2024
| On October 02 2024 Generation Bio Co was traded for 2.51 at the closing time. The top price for the day was 2.74 and the lowest listed price was 2.31 . The trading volume for the day was 303.3 K. The trading history from October 2, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 6.36% . The overall trading delta against the current closing price is 4.24% . |
Generation Bio Fundamentals Correlations and Trends
By evaluating Generation Bio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Generation Bio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Generation financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Generation Bio Stock history
Generation Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Generation is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Generation Bio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Generation Bio stock prices may prove useful in developing a viable investing in Generation Bio
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 64.5 M | 49.9 M | |
| Net Loss | -123 M | -129.1 M |
Generation Bio Quarterly Net Working Capital |
|
Generation Bio Stock Technical Analysis
Generation Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Generation Bio Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Generation Bio Co cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Generation Bio November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Generation Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Generation Bio shares will generate the highest return on investment. By undertsting and applying Generation Bio stock market strength indicators, traders can identify Generation Bio Co entry and exit signals to maximize returns
Generation Bio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Generation Bio's price direction in advance. Along with the technical and fundamental analysis of Generation Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Generation to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (1.24) | |||
| Total Risk Alpha | (1.57) | |||
| Treynor Ratio | (0.26) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.19) | Revenue Per Share 0.28 | Quarterly Revenue Growth 2.52 | Return On Assets (0.19) | Return On Equity (0.86) |
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.